Objectives To determine the prevalence, determinants, and management of dyslipidaemia in
the 25–74-year-old urban black population of Cape Town and examine the changes …

Background: dyslipidemia and obesity are key independent modifiable risk factors for many
non communicable chronic diseases. Patterns of association between these factors may …

Background: Dyslipidemia is a major risk factor for cardiovascular disease. Data are scanty
on the prevalence and pattern of dyslipidemia in Nigeria. However, some studies on the …

Dyslipidemia is commonly associated with diabetes (T2DM). This has been demonstrated
for the Caucasian population, but few data are available for Asian Indians. The paper aims …

Introduction Dyslipidemia is a key clinical abnormality among diabetes mellitus (DM)
patients, which heightens their risk of cardiovascular events. Data on the serum lipid profile …

Background The burden of dyslipidaemia is rising in many low income countries. However,
there are few data on the prevalence of, or risk factors for, dyslipidaemia in Africa. Methods …

Objective To investigate the plasma lipid levels in a national representative sample of
subjects and to determine the prevalence of dyslipidemia in the Chinese population …

Introduction Over 80% of cardiovascular deaths take place in low-and middle-income
countries; most of these deaths are due to modifiable risk factors. The study aimed at …

Background Dyslipidemia is a common public health problem in Africa. It has emerged as an
important cardiovascular risk factor. It has been steadily increasing due to economic growth …

Dyslipidemia is considered a significant modifiable risk factor for type-2 diabetes mellitus
(T2DM) and has become one of the emerging health problems throughout the world. In …